Search Page

1

Cite

Share

Tertiary lymphoid structures in the era of cancer immunotherapy.

Sautès-Fridman C, Petitprez F, Calderaro J, Fridman WH. Sautès-Fridman C, et al. Nat Rev Cancer. 2019 Jun;19(6):307-325. doi: 10.1038/s41568-019-0144-6. Nat Rev Cancer. 2019. PMID: 31092904 Free article. Review.

Cite

Share

2

Cite

Share

Control of tumor development by intratumoral cytokines.

Pages F, Vives V, Sautès-Fridman C, Fossiez F, Berger A, Cugnenc PH, Tartour E, Fridman WH. Pages F, et al. Immunol Lett. 1999 May 3;68(1):135-9. doi: 10.1016/s0165-2478(99)00042-5. Immunol Lett. 1999. PMID: 10397168 Review.

Cite

Share

3

Cite

Share

Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, Sastre-Garau X, Couturier J, Mosseri V, Vives V, Banchereau J, Fridman WH, Wijdenes J, Lebecque S, Sautès-Fridman C. Tartour E, et al. Cancer Res. 1999 Aug 1;59(15):3698-704. Cancer Res. 1999. PMID: 10446984

Cite

Share

4

Cite

Share

Animal models of intraocular lymphomas.

Touitou V, Bodaghi B, de Kozak Y, Lehoang P, Sautès-Fridman C, Fisson S. Touitou V, et al. Ophthalmic Res. 2008;40(3-4):208-11. doi: 10.1159/000119878. Epub 2008 Apr 18. Ophthalmic Res. 2008. PMID: 18421241 Review.

Cite

Share

5

Cite

Share

Selective expression of inhibitory Fcgamma receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response.

Cassard L, Cohen-Solal JF, Fournier EM, Camilleri-Broët S, Spatz A, Chouaïb S, Badoual C, Varin A, Fisson S, Duvillard P, Boix C, Loncar SM, Sastre-Garau X, Houghton AN, Avril MF, Gresser I, Fridman WH, Sautès-Fridman C. Cassard L, et al. Int J Cancer. 2008 Dec 15;123(12):2832-9. doi: 10.1002/ijc.23870. Int J Cancer. 2008. PMID: 18798552 Free article.

Cite

Share

6

Cite

Share

Immune infiltration in human tumors: a prognostic factor that should not be ignored.

Pagès F, Galon J, Dieu-Nosjean MC, Tartour E, Sautès-Fridman C, Fridman WH. Pagès F, et al. Oncogene. 2010 Feb 25;29(8):1093-102. doi: 10.1038/onc.2009.416. Epub 2009 Nov 30. Oncogene. 2010. PMID: 19946335 Review.

Cite

Share

7

Cite

Share

Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.

Cherfils-Vicini J, Platonova S, Gillard M, Laurans L, Validire P, Caliandro R, Magdeleinat P, Mami-Chouaib F, Dieu-Nosjean MC, Fridman WH, Damotte D, Sautès-Fridman C, Cremer I. Cherfils-Vicini J, et al. J Clin Invest. 2010 Apr;120(4):1285-97. doi: 10.1172/JCI36551. Epub 2010 Mar 8. J Clin Invest. 2010. PMID: 20237413 Free PMC article.

Cite

Share

8

Cite

Share

Immune infiltration in human cancer: prognostic significance and disease control.

Fridman WH, Galon J, Dieu-Nosjean MC, Cremer I, Fisson S, Damotte D, Pagès F, Tartour E, Sautès-Fridman C. Fridman WH, et al. Curr Top Microbiol Immunol. 2011;344:1-24. doi: 10.1007/82_2010_46. Curr Top Microbiol Immunol. 2011. PMID: 20512556 Review.

Cite

Share

9

Cite

Share

Tumor microenvironment is multifaceted.

Sautès-Fridman C, Cherfils-Vicini J, Damotte D, Fisson S, Fridman WH, Cremer I, Dieu-Nosjean MC. Sautès-Fridman C, et al. Cancer Metastasis Rev. 2011 Mar;30(1):13-25. doi: 10.1007/s10555-011-9279-y. Cancer Metastasis Rev. 2011. PMID: 21271351 Review.

Cite

Share

10

Cite

Share

The immune microenvironments of lung and intraocular tumors.

Sautès-Fridman C, Dieu-Nosjean MC, Damotte D, Fisson S, Fridman WH. Sautès-Fridman C, et al. Bull Cancer. 2011 Jun;98(6):58-61. doi: 10.1684/bdc.2011.1374. Bull Cancer. 2011. PMID: 21616749 Free article.

Cite

Share